Work

Overall survival and immunologic responses in metastatic pancreatic adenocarcinoma (PDAC) on PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx369.127

Authors: J.R. Hecht, A. Naing, G. Falchook, M.R. Patel, J.R. Infante, R. Aljumaily, D.J. Wong, K. Autio, Z.A. Wainberg, M. Javle, J.C. Bendell, S. Pant, A. Hung, P. Van Vlasselaer, G. Brown, M. Oft, K. Papadopoulos

Institutions: University of California, Los Angeles, The University of Texas MD Anderson Cancer Center, HealthONE, Sarah Cannon, Florida Cancer Specialists & Research Institute, Tennessee Oncology, University of Oklahoma Medical Center, Memorial Sloan Kettering Cancer Center, University of Oklahoma Health Sciences Center, South Texas Accelerated Research Therapeutics

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2763754790

FWCI:

Cites:

Cited by: 1

Related to: 10